tiprankstipranks
Alterity Therapeutics Ltd (ATHE)
NASDAQ:ATHE
US Market
Want to see ATHE full AI Analyst Report?

Alterity Therapeutics (ATHE) Income Statement

301 Followers

Alterity Therapeutics Income Statement

Last quarter (Q2 2026), Alterity Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q2, Alterity Therapeutics's net income was AU$-9.44M. See Alterity Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 5.44MAU$ 4.02MAU$ 3.92MAU$ 5.12MAU$ 4.34M
Gross Profit
AU$ 5.31MAU$ 3.80MAU$ 3.63MAU$ 4.76MAU$ 3.98M
Operating Expenses
AU$ 19.89MAU$ 23.41MAU$ 18.24MAU$ 20.26MAU$ 19.16M
Depreciation and Amortization
AU$ 28.31KAU$ 35.34KAU$ 37.85KAU$ 54.21KAU$ 18.66K
EBITDA
AU$ -14.63MAU$ -19.57MAU$ -14.60MAU$ -17.39MAU$ -15.16M
Operating Income
AU$ -14.57MAU$ -19.60MAU$ -14.64MAU$ -15.50MAU$ -15.18M
Other Income/Expenses
AU$ 2.49MAU$ 524.33KAU$ 904.68KAU$ 2.72MAU$ -133.04K
Pretax Income
AU$ -12.08MAU$ -19.08MAU$ -13.70MAU$ -12.78MAU$ -15.31M
Net Income
AU$ -12.15MAU$ -19.12MAU$ -13.81MAU$ -12.85MAU$ -15.31M
Per Share Metrics
Basic EPS
AU$ -1.14AU$ -3.12AU$ -3.42AU$ -3.18AU$ -5.40
Diluted EPS
AU$ -1.14AU$ -3.12AU$ -3.42AU$ -3.18AU$ -5.40
Weighted Average Shares Outstanding
10.66M 6.08M 4.05M 4.01M 2.83M
Weighted Average Shares Outstanding (Diluted)
10.66M 6.08M 4.05M 4.01M 2.83M
Currency in AUD

Alterity Therapeutics Earnings and Revenue History